Adriaan Verhelle
No current affiliation with UGent
- ORCID iD
-
0000-0002-0912-3723
Show
Sort by
-
Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies
-
Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells
-
- Journal Article
- A1
- open access
VCA nanobodies target N-WASp to reduce invadopodium formation and functioning
-
- PhD Thesis
- open access
Gelsolin amyloidosis : a diagnostic and therapeutic nanobody approach
(2017) -
AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model
-
- Book Chapter
- open access
A nanobody‐based approach to amyloid diseases, the gelsolin case study
-
- Journal Article
- A1
- open access
A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles
-
Non-invasive imaging of amyloid deposits in a mouse model of AGel using 99mTc-modified nanobodies and SPECT/CT
-
An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model
-
- Journal Article
- A1
- open access
A nanobody modulates the p53 transcriptional program without perturbing its functional architecture